Research Report Screener Results

Chart, Financials, Historical Prices, Industry, Insider, Messages, News, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 22-May-2013
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
22-May-13 New Constructs, LLC N/A BCRX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala BIOCRYST PHARMACEUTICALS INC (BCRX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala BIOCRYST PHARMACEUTICALS INC (BCRX) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS 3 $34.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: BIOCRYST PHARM -- BCRX 1 $11.50 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for BCRX 11 $126.50 View Abstract
13-May-13 Zacks Investment Research Inc. N/A BIOCRYST PHARMA (BCRX) Zacks Company Snapshot 1 $11.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOCRYST PHARMACEUTICALS INC 5 $10 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A BioCryst Pharm'l 6 $69 View Abstract
Next 11

Independent Reports (Showing 1 to 10 of 21)

Release
Date Contributor Author Title Pages Price More Info
22-May-13 New Constructs, LLC N/A BCRX: Due Diligence Review: Forensic Earnings and Valuation 13 $25 View Abstract
22-May-13 ValuEngine, Inc. N/A ValuEngine Industry Report for Medical-drugs 18 $207 View Abstract
20-May-13 Pechala's Reports Lubomir Pechala BIOCRYST PHARMACEUTICALS INC (BCRX) - REPORT FOR ACTIVE TRADERS 1 $25 View Abstract
18-May-13 Pechala's Reports Frantisek Pechala BIOCRYST PHARMACEUTICALS INC (BCRX) 12-months forecast 1 $15 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Industry Value Graph: ARRY , BCRX , DNDN , GERN , XOMA -- DRUGS 3 $34.50 View Abstract
17-May-13 Ford Investor Services, Inc. N/A Value Graph: BIOCRYST PHARM -- BCRX 1 $11.50 View Abstract
16-May-13 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for BCRX 11 $126.50 View Abstract
13-May-13 Zacks Investment Research Inc. N/A BIOCRYST PHARMA (BCRX) Zacks Company Snapshot 1 $11.50 View Abstract
12-May-13 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: BIOCRYST PHARMACEUTICALS INC 5 $10 View Abstract
11-May-13 S&P Capital IQ Quantitative Report N/A BioCryst Pharm'l 6 $69 View Abstract
Next 11

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.